Premium
Caesarean scar pregnancy: A 10‐year experience
Author(s) -
Ko Jennifer K.Y.,
Li Raymond H.W.,
Cheung Vincent Y.T.
Publication year - 2015
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.12273
Subject(s) - medicine , methotrexate , pregnancy , gestational sac , obstetrics , gestational age , medical record , retrospective cohort study , medical diagnosis , surgery , ectopic pregnancy , radiology , genetics , biology
Aims To review the management and outcome of all women with caesarean scar pregnancy ( CSP ) at a single centre. Methods A retrospective review of women diagnosed with CSP between J anuary 2004 and D ecember 2013 was performed. Women were identified from the admission and Early Pregnancy Assessment Clinic records. Results Twenty‐two cases of CSP were identified during the study period. The median gestational age at diagnosis was 6.7 weeks (range 4.7–11.8 weeks). All diagnoses were made by ultrasound, the most common finding of which was a heterogeneous mass at the site of the caesarean scar (100%). The median duration for human chorionic gonadotropin to return to undetectable level was 10 weeks (range 2–20 weeks), although the duration for sonographic resolution of the CSP can take much longer. The success rate of intralesional methotrexate was 80% in our series. Conclusion There is no consensus regarding the method of choice for managing CSP . Medical management using intralesional methotrexate appears to be an acceptable treatment in clinically stable women.